• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Butterfly Network Launches Mobile, Whole-Body Ultrasound with Integrated Telehealth Platform

Share:

October 14, 2020

Highlights on this story:
  • Butterfly Network launched its next-gen ultrasound product, the new Butterfly iQ+ featuring the world’s only Ultrasound-on Chip™ technology and announced a landmark collaboration with the American College of Cardiology (ACC).

Butterfly Network, Inc., today announced the launch of its next-gen ultrasound product, the new Butterfly iQ+, the world’s only single-probe, whole-body ultrasound system that connects to a mobile device and features an integrated telemedicine platform. Butterfly iQ+ offers new capabilities, such as faster frame rates, Needle VizTMtechnology, a longer battery life and industry-leading durability.

Ultrasound reinvented again

Butterfly iQ+ features an optimized manufacturing process in partnership with TSMC, the largest and most advanced dedicated IC foundry in the world. TSMC’s MEMS (microelectromechanical systems) manufacturing technology enables the ultrasound transducer to seamlessly integrate with CMOS (complementary metal-oxide semiconductor) technology. In addition, TSMC possesses manufacturing capacity that can scale to realize Butterfly’s vision of making an ultrasound device as ubiquitous as the stethoscope for the world’s 40 million healthcare providers.

Butterfly’s innovative product has been shown to be a particularly useful tool during the global COVID-19 pandemic due to its lung imaging capabilities, portability and ease of cleaning, as infection control has become increasingly important. Butterfly iQ+ brings a suite of new capabilities that make it even easier to make fast decisions at the bedside.

Faster, sharp imaging

With patented on-chip digital micro-beamforming enabling 15% faster frame rates and 60% faster pulse repetition frequency, healthcare providers can see image details in the heart, lungs and bladder with optimized clarity. High-performance shallow imaging capabilities help support fast, confident interventional decision-making, while deep imaging capabilities in the lung and deep cardiac presets allow for sharp details. The Butterfly iQ+ can help healthcare providers save time in their diagnosis and treatment of patients, improving overall patient outcomes.

State-of-the-art technology for new levels of control

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

The cutting-edge Needle VizTM technology available on Butterfly iQ+ can provide healthcare professionals with an enhanced ability to see a needle—improving confidence for central line placements, regional nerve blocks and other guided procedures. Additionally, in just four seconds, clinicians can calculate bladder volume automatically using the AI-based Auto Bladder Volume tool, allowing faster decisions at the bedside.

More power and durability

The Butterfly iQ+ extends battery life by 20% and scanning time by 100% to help healthcare providers get through their shift. With its durable, anodized aluminum body and replaceable compression- and stomp-tested cable, the Butterfly iQ+ offers military-grade durability to withstand tough shifts, and has been tested to withstand an industry-leading 4-foot drop. This next-generation device has gone through rigorous testing to ensure shock resistance and protection from dust and water damage.

Pricing & Availability

Putting ultrasound on a chip, Butterfly was able to define a new precedent of affordability by providing a whole-body ultrasound device at $1,999, plus membership. Today, as it reinvents ultrasound again, Butterfly iQ+ will be available for the same affordable price.

“Two years ago, Butterfly introduced the world’s first handheld, single-probe, whole-body ultrasound system. Since then, the device has been used by tens of thousands of medical professionals across the globe with significant clinical, economic and societal impact,” said Laurent Faracci, Butterfly Network’s Chief Executive Officer. “We have collaborated with the Butterfly community of users to define our innovation path. The first result in that journey is the new Butterfly iQ+, a big step forward for point-of-care ultrasound, with our most advanced chip ever and a number of amazing innovations and improvements that our talented team and partners developed.”

Source: Hit Consultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • COVID-19 Vulnerability Index Identifies Urban Populations at High RiskCOVID-19 Vulnerability Index Identifies Urban Populations at High Risk
  • Wheel Integrates with GoodRx for Real-Time Medication Pricing & DiscountsWheel Integrates with GoodRx for Real-Time Medication Pricing & Discounts
  • QSAM Biosciences Signs Term Sheet to be Acquired by Telix Pharmaceuticals; Receives $2 Million Pre-Closing Collaboration and Option FeeQSAM Biosciences Signs Term Sheet to be Acquired by Telix Pharmaceuticals; Receives $2 Million Pre-Closing Collaboration and Option Fee
  • 3M to acquire M*Modal’s cloud AI technology for $1B3M to acquire M*Modal’s cloud AI technology for $1B
  • Analysis: August Health IT M&A Activity; Public Company PerformanceAnalysis: August Health IT M&A Activity; Public Company Performance
  • EUSA Pharma Announces Sale of Critical Care Business to SERB PharmaceuticalsEUSA Pharma Announces Sale of Critical Care Business to SERB Pharmaceuticals
  • Rally Health Launches Next-Gen Consumer Digital Health PlatformRally Health Launches Next-Gen Consumer Digital Health Platform
  • Sight Diagnostics Nabs $71M to Expand FDA-Cleared Finger-Prick Blood AnalyzerSight Diagnostics Nabs $71M to Expand FDA-Cleared Finger-Prick Blood Analyzer

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications